Raadr Inc (RDAR)

[Bubae]

Traders of this stock are supposed to disregard what is in the company's own print because you try to cast doubt on the messengers motivations. Brilliant. 🙄 It is clear that Mexedia needs this access to the U.S. capital market to serve as a lifeline for what looks on paper to be a failing business. Three billion shares added to the float in just three months to retire Raadr debt and more left. The new management has been selling a false narrative and it is clear why. So far so good. Watching for the SEC qualification of the regulation A offering and how the company plans to con OTC traders into buying it. That five year plan revealed nothing new, just more promotion for 2023 numbers, the business that was. Good luck with your flip.

Bubae
Re: None
Friday, January 24, 2025 6:54:21 AM
Post# 39918 of 40359
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175708768

The December 02, 2024 press release is another example of new management deception. the $150K Tri-Bridge Ventures convertible note that converts at 50% discount to lowest bid price in the preceding 25 days has been on the books and is still outstanding according to the Q3 released on January 15th 2025. The new CFO stated that "Moving forward, all new financing will be derived from equity or instruments with fixed-price features..." If you look at the chart below we see that just three days after the press release they write the first of three notes in December with a variable rate feature, a 25% discount to the price of the regulation A offering. You can bet the eventual amended offering price will be at a steep discount to market, then add another 25%. Yeah, you should hang on every word the new management issues in a press release. 🙄

Bubae
Re: just Scottie post# 39345
Friday, January 17, 2025 9:11:02 AM
Post# 39362 of 40359
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175678987&txt2find=owner%2Borlando

You might want to pay more attention to the the statement in that press release by the owner of Mexedia, Orlando Taddeo, the author of that shareholder letter. This person is boasting about Mexedia's 2023 financials knowing that 2024 numbers have fallen off a cliff. This merger agreement turned Raadr, now Telvantis, into a simple holding company of which Mexedia owns 75% of through the series F preferred shares handed over for nothing in the merger agreement. It doesn't work however unless they can con OTC retail into buying the regulation A offering shares. How do they make the $4.5 million priced at $0.003 offering viable? Amended price maybe, reverse split? We share see. One thing is for certain, they are desperate to get those shares sold. Watch for more misinformation to come in both the press releases and this board.